Exploring safe dosage levels for new therapeutic compounds.
IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2
This study is looking for safe dosage levels for new treatments aimed at helping people with neurological conditions, and if you join, you could help test these promising therapies to see how well they work and if they're safe for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iit Research Institute NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11212035 on NIH RePORTER |
What this research studies
This research focuses on determining safe dosage ranges for new therapeutic compounds, including small molecules and peptides, through early-stage clinical trials. The study utilizes a network of experienced contract service providers to facilitate the development of these compounds, ensuring they are ready for Phase I clinical testing. Patients may be involved in trials that assess the safety and efficacy of these new treatments, contributing to the advancement of neurological therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals with neurological conditions who are seeking new treatment options.
Not a fit: Patients with conditions not addressed by the therapeutic compounds being tested may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective treatments for neurological disorders.
How similar studies have performed: Previous research has shown success in similar approaches, indicating a promising pathway for developing new neurological therapies.
Where this research is happening
Chicago, United States
- Iit Research Institute — Chicago, United States (Active)
Researchers
- Principal investigator: O'ryan, Michael — Iit Research Institute
- Study coordinator: O'ryan, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.